These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 37948481)

  • 1. Values of Immunoglobulin and Complements for Evaluating Treatment Outcomes of Patients with Multiple Myeloma.
    Liu X; Zhou Z; Sun D
    Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
    Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
    Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of Serum Light Chain in Diagnosis and Evaluation of Efficacy for Multiple Myeloma].
    Yu Y; Teng XJ; Luo GL; Wu LX; Guo BQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Jun; 28(3):886-893. PubMed ID: 32552953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Value of sFLC and Serum Calcium in the Diagnosis and Prognosis of Multiple Myeloma Patients].
    Pei XH; Zhang LN; Zhou P; Wang TB; Lian C; Zhang P; Lei PC; Zhu ZM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Jun; 32(3):794-798. PubMed ID: 38926969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Analysis of Relationship between Serum Total Light Chain κ/λ Ratio and Proportion of Bone Marrow Plasma Cells in Patients with IgG type and IgA type Multiple Myeloma].
    Zhu AY; Zhu FB; Wang FC; Zhang LJ; Ma Y; Hu JG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1454-1459. PubMed ID: 29070124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Analysis of monoclonal protein in 72 cases of multiple myeloma].
    Yang JJ; Zhang GS; Chen XR
    Hunan Yi Ke Da Xue Xue Bao; 2001 Apr; 26(2):152-4. PubMed ID: 12536652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of differences in immunoglobulin heavy/light chain pairs (Hevylite), selected laboratory parameters and stratification systems in different immunochemical types of multiple myeloma.
    Scudla V; Lochman P; Pika T; Minarik J; Zapletalova J; Bacovsky J
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):84-93. PubMed ID: 26365929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical Significance of Serum Free Light Chain and Its κ/λ Ratio in Patients with Multiple Myeloma].
    Zhao D; Jiang JQ; Lin L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Aug; 27(4):1173-1178. PubMed ID: 31418375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Capillary Electrophoresis in Monoclonal Gammopathies and the Cutoff Value of Monoclonal Protein in Differential Diagnosis of Multiple Myeloma and Other Monoclonal Gammopathies.
    Cao F; Zhang R; Xu L; Liu M; Yuan Y
    Ann Clin Lab Sci; 2021 May; 51(3):400-407. PubMed ID: 34162571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of Serum Free Light Chain Kappa/Lambda Ratio Detection Combined with Immunofixation Electrophoresis in the Prognosis Evaluation of Patients with Multiple Myeloma].
    Jiang XN; Chen JF; Wang Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Feb; 28(1):191-195. PubMed ID: 32027275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interpretation Difficulties of Serum Immunofixation Test in Immunoglobulin D Multiple Myeloma with Hidden Lambda Light Chains.
    Biaz A; Uwingabiye J; Rachid A; Dami A; Bouhsain S; Ouzzif Z; Idrissi SEM
    Clin Lab; 2018 Jun; 64(6):1065-1069. PubMed ID: 29945318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to therapy in IgG myeloma patients excreting lambda or kappa light chains: CALGB experience.
    Cornell CJ; McIntyre OR; Kochwa S; Weksler BB; Pajak TF
    Blood; 1979 Jul; 54(1):23-9. PubMed ID: 109133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kappa and lambda light chain disease: survival rates and clinical manifestations.
    Shustik C; Bergsagel DE; Pruzanski W
    Blood; 1976 Jul; 48(1):41-51. PubMed ID: 820387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
    Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
    Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Test of Serum Free Light Chain and Its Clinical Significance in Light Chain Multiple Myeloma].
    Song P; An ZM; Zhou XG; Li F; Wang LP; Zhao Q; Yu YP; Zhai YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1357-61. PubMed ID: 26524037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical Migration in Serum Immunofixation of Immunoglobulin A with Masked kappa Light Chains: a Case Report and Review of the Literature.
    Biaz A; Laamara L; Mahtat E; Bouhsain S; Doghmi K; Dami A; Elmachtani-Idrissi S
    Clin Lab; 2023 Apr; 69(4):. PubMed ID: 37057941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Serum Free Light Chains Measurements in Multiple Myeloma Patients.
    García de Veas Silva JL; Bermudo Guitarte C; Menéndez Valladares P; Rojas Noboa JC; Kestler K; Duro Millán R
    PLoS One; 2016; 11(11):e0166841. PubMed ID: 27893836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
    Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
    Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concentrations of Serum Free Light Chains in Kappa and Lambda Lesions in Light-Chain Myelomas.
    Singh G
    Lab Med; 2019 Apr; 50(2):189-193. PubMed ID: 30423164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three M-components IgA lambda + IgG kappa n + IgG kappa h in one patient (DA): lack of shared idiotypic determinants between IgA and IgG, and the presence of an unusual kappa h chain of 30,000 M.W.
    Bouvet JP; Liacopoulos P; Pillot J; Banda R; Tung E; Wang AC
    J Immunol; 1980 Jul; 125(1):213-20. PubMed ID: 6769997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.